These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16847121)

  • 1. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
    Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
    J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.
    Lin Y; Kwon T; Polo J; Zhu YF; Coates S; Crawford K; Dong C; Wininger M; Hall J; Selby M; Coit D; Medina-Selby A; McCoin C; Ng P; Drane D; Chien D; Han J; Vajdy M; Houghton M
    J Virol; 2008 Aug; 82(15):7492-503. PubMed ID: 18508900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.
    Qiu Q; Wang RY; Jiao X; Jin B; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Vaccine; 2008 Oct; 26(43):5527-5534. PubMed ID: 18675871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
    Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
    Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
    Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
    J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity and heterologous protection in mice with a recombinant adenoviral-based vaccine carrying a hepatitis C virus truncated NS3 and core fusion protein].
    Guan J; Deng Y; Chen H; Yang Y; Wen B; Tan W
    Bing Du Xue Bao; 2015 Jan; 31(1):7-13. PubMed ID: 25997323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
    Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X
    J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2004 Jun; 85(Pt 6):1533-1543. PubMed ID: 15166437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
    Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
    J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
    Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
    Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunogenicity of a multi-epitope peptide vaccine candidate based on hepatitis C virus NS5A, NS4B and core proteins in HHD-2 mice.
    Huang XJ; Lü X; Lei YF; Yang J; Yao M; Lan HY; Zhang JM; Jia ZS; Yin W; Xu ZK
    J Virol Methods; 2013 Apr; 189(1):47-52. PubMed ID: 23333413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
    Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
    Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
    Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.